NYLIM
PMVP icon

New York Life Investment Management’s PMV Pharmaceuticals PMVP Stock Holding History

New York Life Investment Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-72,683
Closed -$225K – 1485
2023
Q4 		$225K Sell
72,683
-1,842
-2% -$4.87K ﹤0.01% 1279
2023
Q3 		$458K Sell
74,525
-11,876
-14% -$81.7K ﹤0.01% 798
2023
Q2 		$541K Sell
86,401
-6,962
-7% -$36.5K 0.01% 675
2023
Q1 		$445K Buy
+93,363
New +$657K 0.01% 1141

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

New York Life Investment Management's PMVP Position: Q1 2024 in Review

New York Life Investment Management sold out of PMV Pharmaceuticals (PMVP) in Q1 2024, closing a stake of 72,683 shares — an estimated $225K sold.

New York Life Investment Management first reported a position in PMVP in Q1 2023 and held it in 4 quarters. The position peaked at $541K in Q2 2023. 99 funds tracked by Wall St. Rank hold PMVP as of Q1 2024.

  • New York Life Investment Management reported no remaining PMV Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 72,683 PMV Pharmaceuticals shares in Q1 2024, an estimated $225K.
  • New York Life Investment Management first reported a position in PMV Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's PMV Pharmaceuticals position peaked at $541K in Q2 2023.
  • 99 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.